Literature DB >> 9150937

A comparison of selected mRNA and protein abundances in human liver.

L Anderson1, J Seilhamer.   

Abstract

In order to obtain an estimate of the overall level of correlation between mRNA and protein abundances for a well-characterized pharmaceutically relevant biological system, we have analyzed human liver by quantitative two-dimensional electrophoresis (for protein abundances) and by Transcript Image methodology (for mRNA abundances). Incyte's LifeSeq database was searched for expressed sequence tag (EST) sequences corresponding to a series of 23 proteins identified on 2-D maps in the Large Scale Biology (LSB) Molecular Anatomy database, resulting in estimated abundances for 19 messages (4 were undetected) among 7926 liver clones sequenced. A correlation coefficient of 0.48 was obtained between the mRNA and protein abundances determined by the two approaches, suggesting that post-transcriptional regulation of gene expression is a frequent phenomenon in higher organisms. A comparison with published data (Kawamoto, S., et al., Gene 1996, 174, 151-158) on the abundances of liver mRNAs for plasma proteins (secreted by the liver) suggests that higher abundance messages are strongly enriched in secreted sequences. Our data confirms this: of the 50 most abundant liver mRNAs, 29 coded for secreted proteins, while none of the 50 most abundant proteins appeared to be secreted products (although four plasma and red blood cell proteins were present in this group as contaminants from tissue blood).

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9150937     DOI: 10.1002/elps.1150180333

Source DB:  PubMed          Journal:  Electrophoresis        ISSN: 0173-0835            Impact factor:   3.535


  205 in total

1.  Detecting selective expression of genes and proteins.

Authors:  L D Greller; F L Tobin
Journal:  Genome Res       Date:  1999-03       Impact factor: 9.043

2.  Relating whole-genome expression data with protein-protein interactions.

Authors:  Ronald Jansen; Dov Greenbaum; Mark Gerstein
Journal:  Genome Res       Date:  2002-01       Impact factor: 9.043

3.  Gene induction during differentiation of human monocytes into dendritic cells: an integrated study at the RNA and protein levels.

Authors:  C Angénieux; D Fricker; J M Strub; S Luche; H Bausinger; J P Cazenave; A Van Dorsselaer; D Hanau; H de la Salle; T Rabilloud
Journal:  Funct Integr Genomics       Date:  2001-09       Impact factor: 3.410

4.  Proteomic approach for the elucidation of biological defects in autism.

Authors:  M A Junaid; R K Pullarkat
Journal:  J Autism Dev Disord       Date:  2001-12

5.  Application of laser capture microdissection and proteomics in colon cancer.

Authors:  L C Lawrie; S Curran; H L McLeod; J E Fothergill; G I Murray
Journal:  Mol Pathol       Date:  2001-08

Review 6.  Molecular biologist's guide to proteomics.

Authors:  Paul R Graves; Timothy A J Haystead
Journal:  Microbiol Mol Biol Rev       Date:  2002-03       Impact factor: 11.056

7.  Identification and differential expression of two thioredoxin h isoforms in germinating seeds from pea.

Authors:  Françoise Montrichard; Michelle Renard; Fatima Alkhalfioui; Frédéric D Duval; David Macherel
Journal:  Plant Physiol       Date:  2003-07       Impact factor: 8.340

Review 8.  The application of 2D gel-based proteomics methods to the study of breast cancer.

Authors:  Robert C Stein; Marketa J Zvelebil
Journal:  J Mammary Gland Biol Neoplasia       Date:  2002-10       Impact factor: 2.673

9.  Identification of proteomic differences between squamous cell carcinoma of the lung and bronchial epithelium.

Authors:  Gereon Poschmann; Barbara Sitek; Bence Sipos; Anna Ulrich; Sebastian Wiese; Christian Stephan; Bettina Warscheid; Günter Klöppel; Ann Vander Borght; Frans C S Ramaekers; Helmut E Meyer; Kai Stühler
Journal:  Mol Cell Proteomics       Date:  2009-01-27       Impact factor: 5.911

10.  Proteomics in zebrafish exposed to endocrine disrupting chemicals.

Authors:  E A Shrader; T R Henry; M S Greeley; B P Bradley
Journal:  Ecotoxicology       Date:  2003-12       Impact factor: 2.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.